Document Detail

Intravenous sodium valproate in status epilepticus.
MedLine Citation:
PMID:  14652464     Owner:  NLM     Status:  MEDLINE    
A study was conducted to observe the effect of intravenous sodium valproate in status epilepticus. Eleven patients with status epilepticus, who were resistant to conventional drugs, underwent treatment with intravenous sodium valproate. The seizures were controlled in 10 patients within 24-48 hrs of starting treatment. No complications were observed during therapy. We conclude that intravenous sodium valproate can be recommended for Myoclonic status epilepticus and non-convulsive status epileticus.
S Jha; M Jose; R Patel
Related Documents :
2149804 - Adverse effects of antiepileptic drugs on the nervous system.
24983264 - Can aerobic exercise complement antihypertensive drugs to achieve blood pressure contro...
24250674 - Improvement of capillary electrophoretic enantioseparation of fluoxetine by a cationic ...
24421484 - Approvals, submission, and important labeling changes for us marketed pharmaceuticals.
21343404 - The sources and popularity of online drug information: an analysis of top search engine...
11126694 - Clinical drug trials: practical problems of phase iii.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Neurology India     Volume:  51     ISSN:  0028-3886     ISO Abbreviation:  Neurol India     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-12-03     Completed Date:  2004-08-03     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0042005     Medline TA:  Neurol India     Country:  India    
Other Details:
Languages:  eng     Pagination:  421-2     Citation Subset:  IM    
Department of Neurology, Sanjay Gandhi PGIMS, Lucknow, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticonvulsants / administration & dosage*
Injections, Intravenous
Middle Aged
Status Epilepticus / drug therapy*
Treatment Outcome
Valproic Acid / administration & dosage*
Reg. No./Substance:
0/Anticonvulsants; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Merosin negative congenital muscular dystrophy: a short report.
Next Document:  The effect of a fear-avoidance-based physical therapy intervention for patients with acute low back ...